Compromised Outcomes in Stage IV Non???Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data Article (Faculty180)

cited authors

  • Scott, Jeffrey A.; Lennerz, Jochen; Johnson, Melissa Lynne; Gordan, Lucio N.; Dumanois, Robert H.; Quagliata, Luca; Ritterhouse, Lauren L.; Cappuzzo, Federico; Wang, Brandon; Xue, Mei; Vasudevan, Anupama; Varughese, Prateesh; Vaidya, Varun; Gart, Mike; Dorrow, Natalie; Gierman, Hinco J.; Choksi, Rushir J.


publication date

  • 2023

published in

start page

  • OP.22.00611